Slide 1: Welcome Investors
Welcome Investors June 2026 1
Slide 2: Forward Looking Statements
Forward Looking Statements Some of the statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). Management and representat
Slide 3: Investment Overview
Investment Overview UFP Technologies is a trusted contract $603M $1.7B* development and manufacturing organization Revenue (2025) Market Cap specializing in comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. NASDAQ: UFPT | Newburyport, Massac
Slide 4: Attractive Market Opportunity
Attractive Market Opportunity Large, growing, regulated, and fragmented with serial innovation ~$518B ~$100B ~15+ 1 2 Global Medical Outsourcing Major Market Device Market Opportunity Segments ~6.3% CAGR1 ~10% CAGR2 ~75 Sub-Segments UFP's Core Focus on Plastic Products Growing Segments Single Use Di
Slide 5: What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes
What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes Developing new innovations into long-term manufacturing revenue WHO WE SERVE Large Global OEMs Niche Device Makers Well-Funded Start-Ups WHAT WE DO Early Development Scale & Optimize Full Production Design, prototyping
Slide 6: What We Do: Turning Product Ideas into Reality with Material Technology
What We Do: Turning Product Ideas into Reality with Material Technology Robotic Drapes Access Port Surgical Site Pacemaker Catheter Sterile Barriers Implants Patient Beds Surgical Screws NPWT Dressing Patient Transfer RAS Patient Beds Cardiovascular Infection Control Orthopedics Wound Care 6 Confide
Slide 7: Differentiation and Competitive Advantage
Differentiation and Competitive Advantage Innovate and scale with engineering, material, and manufacturing expertise Durable 1 Design In Early 2 Scale & Optimize 3 Relationships Ability to make technology Experience and trust to High switching costs secures available at the front-end of scale with a
Slide 8: Segment Focus
Segment Focus Exposure to growth medical segments offering differentiated single-use technologies to improve patient outcomes and deliver value ~13-17% ~6% ~6.5-7% Robotic Assisted Surgery CAGR* CAGR* CAGR* Patient Beds & Handling Cardiovascular ~5.5-6.5% ~4-5% ~5-6% CAGR* CAGR* CAGR* Infection Cont
Slide 9: Strategy to Win
Strategy to Win Disciplined strategy designed to compound revenue and earnings through organic growth and customer-centric acquisitions 12-18% Blended Annual Growth Target Customer-Centric M&A Organic Growth • Onboard partner • Differentiated material companies to technologies in faster- decentraliz
Slide 10: Proven Financial Performance
Proven Financial Performance Consistent multi-year growth with meaningful margin expansion Revenue ($M) & Adj. Operating Margin 700 70% 3.4× $603 Revenue growth 2020–2025 600 $554 60% 500 $428 50% 28.6% 400 40% Gross Margin (2025) $311 300 30% 200 $179 $218 13.8% 16.4% 18.3% 17.1% 20% 17.1% 11.1% 10
Slide 11: Clear Financial Framework and Capital Discipline
Clear Financial Framework and Capital Discipline Clear financial targets supported by disciplined capital allocation and leverage philosophy 3–5 Year Financial Targets 12–18% 28–31% 17–20% Annual Revenue Gross Adj. Operating Growth Margins Margins 11 Confidential, property of UFP Technologies, Inc.
Slide 12: Experienced Management Team
Experienced Management Team Deep MedTech expertise driving decentralized platform execution Mitch Rock Ron Lataille Ryan Stafford Jason Holt President & CEO CFO, SVP & Treasurer General Counsel & SVP HR SVP 33 yrs at UFP 29 yrs at UFP Former EVP LFUS Former ITW, 8 yrs at UFP Marcelo Soliz Daniel Lee
Slide 13: Why Invest Now?
NASDAQ: UFPT Why Invest Now? investorinfo@ufpt.com www.ufpt.com A High-Quality MedTech Platform Built to Compound Value Over Time Large, growing, fragmented market Differentiated technology embedded with customers Driving better patient outcomes and durable growth Experienced team with operating pla
Slide 14: Thank You!
Thank You! aa UFP ‘ww TECHNOLOGIES 14